Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

During the Trading Day
11.78 +0.06 / +0.51%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.00 +0.22 / +1.87%
 
Volume: 36.7K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-79.7M-91.8M-130.7M--
 
 
 
 
Depreciation5.3M3.7M2.6M--
 
 
 
 
Total Other Cash Flow7.1M6.4M15.9M--
 
 
 
 
Funds From Operations-66.1M-81.7M-112.2M--
 
 
 
 
Funds From/For Other Operating Expenses-13.2M-1.9M-17.1M--
 
 
 
 
Net Cash Flow - Operating Activities-52.8M-79.8M-95.2M-34.8M
 
 
 
 
 
 
InvestingIncrease In Investments0.00-115.7M-112.9M--
 
 
 
Decrease In Investments0.0043.9M95.1M--
 
 
 
Capital Expenditures-3.8M-3.2M-9.9M--
 
 
 
 
Other Investing - Uses0.00-628.0K-59.0K--
 
 
 
Other Investing - Sources7.0K381.0K0.00--
 
 
 
Net Cash Flow Investing-3.7M-75.2M-27.7M-6.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.0041.1M121.5M--
 
 
 
Long Term Debt Reduction-443.0K-48.0K0.00--
 
 
 
Net Proceeds Stock Sale78.7M105.5M28.8M--
 
 
 
 
Common Preferred Redeemed0.000.000.00----
Common Dividends0.000.000.00----
Cash Dividends Paid - Total0.00-4.2M-3.0K--
 
 
 
Other Sources - Financing0.000.000.00----
Other Uses - Financing1.9M0.000.00--
 
 
Net Cash Flow - Financing76.3M142.3M150.3M11.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash19.7M-12.7M27.4M-29.4M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account